XML 19 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Capital in Excess of Par Value
Retained Earnings
Retained Earnings
Cumulative effect, period of adoption, adjustment
Accumulated Other Comprehensive Loss
Accumulated Other Comprehensive Loss
Cumulative effect, period of adoption, adjustment
Beginning balance (in shares) at Nov. 02, 2019   368,302          
Beginning balance at Nov. 02, 2019   $ 61,385 $ 4,936,349 $ 6,899,253 $ 2,379 $ (187,799) $ (2,379)
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income $ 834,235     834,235      
Dividends declared and paid       (656,558)      
Issuance of stock as charitable contribution (in shares)   336          
Issuance of stock as charitable contribution   $ 56 39,944        
Issuance of stock under stock plans and other (in shares)   2,730          
Issuance of stock under stock plans and other   $ 455 57,295        
Stock-based compensation expense     112,961        
Other comprehensive income (loss) (82,751)         (82,751)  
Common stock repurchased (in shares)   (2,202)          
Common stock repurchased   $ (367) (236,898)        
Ending balance (in shares) at Aug. 01, 2020   369,166          
Ending balance at Aug. 01, 2020   $ 61,529 4,909,651 7,079,309   (272,929)  
Beginning balance (in shares) at May. 02, 2020   368,425          
Beginning balance at May. 02, 2020   $ 61,405 4,861,013 6,945,442   (277,002)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 362,665     362,665      
Dividends declared and paid       (228,798)      
Issuance of stock under stock plans and other (in shares)   892          
Issuance of stock under stock plans and other   $ 149 26,704        
Stock-based compensation expense     39,560        
Other comprehensive income (loss) 4,073         4,073  
Common stock repurchased (in shares)   (151)          
Common stock repurchased   $ (25) (17,626)        
Ending balance (in shares) at Aug. 01, 2020   369,166          
Ending balance at Aug. 01, 2020   $ 61,529 4,909,651 7,079,309   (272,929)  
Beginning balance (in shares) at Oct. 31, 2020   369,485          
Beginning balance at Oct. 31, 2020 11,997,945 $ 61,582 4,949,586 7,236,238   (249,461)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 1,314,735     1,314,735      
Dividends declared and paid       (738,114)      
Issuance of stock under stock plans and other (in shares)   2,040          
Issuance of stock under stock plans and other   $ 340 55,008        
Stock-based compensation expense     118,683        
Other comprehensive income (loss) 24,518         24,518  
Common stock repurchased (in shares)   (3,311)          
Common stock repurchased   $ (552) (508,600)        
Ending balance (in shares) at Jul. 31, 2021   368,214          
Ending balance at Jul. 31, 2021 12,263,963 $ 61,370 4,614,677 7,812,859   (224,943)  
Beginning balance (in shares) at May. 01, 2021   368,827          
Beginning balance at May. 01, 2021   $ 61,472 4,724,493 7,564,054   (182,915)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income 503,311     503,311      
Dividends declared and paid       (254,506)      
Issuance of stock under stock plans and other (in shares)   396          
Issuance of stock under stock plans and other   $ 66 11,610        
Stock-based compensation expense     41,687        
Other comprehensive income (loss) (42,028)         (42,028)  
Common stock repurchased (in shares)   (1,009)          
Common stock repurchased   $ (168) (163,113)        
Ending balance (in shares) at Jul. 31, 2021   368,214          
Ending balance at Jul. 31, 2021 $ 12,263,963 $ 61,370 $ 4,614,677 $ 7,812,859   $ (224,943)